Li Xiang-Ri, Wei Feng, Cao Hui
Chinese Medicine Processing Research Center, Beijing Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Beijing University of Chinese Medicine Beijing 102488, China.
Institute for the Determination of Traditional Chinese Medicine and Ethnic Medicine, National Institutes for Food and Drug Control Beijing 102629, China.
Zhongguo Zhong Yao Za Zhi. 2021 Sep;46(17):4585-4590. doi: 10.19540/j.cnki.cjcmm.20210121.301.
As the last procedure of traditional Chinese medicine(TCM) applied in clinical practice, prescription-based processing(PBP) is an important guarantee for the quality and clinical efficacy of TCM, which can not only maximize the effect of processed product, but also exert the characteristics of syndrome differentiation and treatment in TCM. However, due to various reasons, most medical institutions have no PBP business. As a result, doctors can only use the conventional decoction pieces available on the market, which also greatly limits their flexible medication, with certain impacts on the normal development of the curative effect of TCM. Therefore, the article explained the necessity of PBP from three aspects. In addition, according to Chinese Pharmacopoeia and the characte-ristics of TCM decoction pieces, the varieties suitable for PBP were summarized and proposed, and also some suggestions about developing PBP are given. The PBP is one of the characteristic techniques in TCM, with special technical requirements and profound scientific connotation. The development of PBP will not only promote the processing of TCM and ensure the clinical efficacy, but also promote the vigorous development of TCM.
作为中医临床应用的最后一道工序，中药配方颗粒是中药质量和临床疗效的重要保障，它不仅能使炮制产品的效果最大化，还能发挥中医辨证论治的特点。然而，由于各种原因，大多数医疗机构没有中药配方颗粒业务。因此，医生只能使用市场上现有的传统饮片，这也极大地限制了他们用药的灵活性，对中医疗效的正常发挥有一定影响。为此，文章从三个方面阐述了中药配方颗粒的必要性。此外，根据《中国药典》和中药饮片的特点，总结并提出了适合中药配方颗粒的品种，还给出了一些发展中药配方颗粒的建议。中药配方颗粒是中医特色技术之一，有特殊的技术要求和深刻的科学内涵。中药配方颗粒的发展不仅会促进中药炮制，确保临床疗效，还会推动中医蓬勃发展。
